5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 10.40▲ | 10.40▲ | 10.40▲ | 10.41▲ | 10.40▲ |
MA10 | 10.39▲ | 10.39▲ | 10.39▲ | 10.40▲ | 10.40▲ |
MA20 | 10.38▲ | 10.38▲ | 10.38▲ | 10.40▲ | 10.34▲ |
MA50 | 10.28▲ | 10.24▲ | 10.23▲ | 10.39▲ | N/A |
MA100 | N/A | N/A | N/A | 10.32▲ | N/A |
MA200 | N/A | N/A | N/A | 10.20▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.006▼ | -0.007▼ | -0.007▼ | 0.001▲ | -0.005▼ |
RSI | 81.827▲ | 81.227▲ | 81.124▲ | 68.669▲ | 78.503▲ |
STOCH | 69.167 | 80.278▲ | 80.278▲ | 76.477 | 74.144 |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -45.714 | -20.000▲ |
CCI | 156.413▲ | 168.711▲ | 168.711▲ | 142.481▲ | 108.530▲ |
Thursday, July 17, 2025 01:46 AM
The firm is headquartered at the Empire State Building in New York City and is investigating Voyager Acquisition Corp. (NASDAQ: VACH) related to its merger with Veraxa Biotech AG.
|
Wednesday, July 16, 2025 06:00 PM
Xlife Sciences AG / Key word (s): IPO/Merger Xlife Sciences AG's Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4 17.07.2025 / 07:00 CET/CEST The ...
|
Tuesday, July 01, 2025 09:08 AM
Nasdaq handily beat the New York Stock Exchange in stock market listings during the first half of 2025, buoyed by blockbuster initial public offerings of big names like CoreWeave and Chime and a ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 10.40 | 10.418 | 10.40 | 10.418 | 4,700 |
14/08/25 | 10.45 | 10.45 | 10.40 | 10.41 | 4,989 |
13/08/25 | 10.40 | 10.40 | 10.40 | 10.40 | 17,700 |
12/08/25 | 10.40 | 10.40 | 10.40 | 10.40 | 20,102 |
11/08/25 | 10.40 | 10.402 | 10.40 | 10.402 | 2,800 |
08/08/25 | 10.40 | 10.40 | 10.40 | 10.40 | 2,700 |
07/08/25 | 10.40 | 10.40 | 10.40 | 10.40 | 2,900 |
06/08/25 | 10.40 | 10.40 | 10.40 | 10.40 | 3,361 |
05/08/25 | 10.39 | 10.40 | 10.39 | 10.40 | 5,700 |
04/08/25 | 10.40 | 10.40 | 10.39 | 10.40 | 12,200 |
|
|
||||
|
|
||||
|
|